Review




Structured Review

NSABP Foundation sentinel lymph node biopsy
Sentinel Lymph Node Biopsy, supplied by NSABP Foundation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sentinel+lymph+node+biopsy/sentinel+lymph+node+biopsy/pmc12159821-43-23-12
Average 90 stars, based on 1 article reviews
sentinel lymph node biopsy - by Bioz Stars, 2026-10
90/100 stars

Images

Related Articles

other:

Article Title: Sentinel node in breast cancer as an indicator of quality in medical care: Evaluation of statistics in Colombia
Article Snippet: BACKGROUND: Sentinel lymph node biopsy in breast cancer is considered the standard of staging in cases of clinically negative lymph nodes.. Its omission in favor of axillary dissection generates significant morbidity.. OBJECTIVE: To determine the total number of sentinel node biopsy procedures in breast cancer in Colombia from 2017 through 2020, model and analyze them as if they were performed only in stage I breast cancer patients, and integrate their results into the concepts of quality of medical care.

Adjuvant:

Article Title: Cervical lymphatic tissue as an alternative donor site for the microsurgical treatment of secondary lymphedema in limbs.
Article Snippet: .. The B-32 trial of the National Surgical Adjuvant Breast and Bowel Project (NSABP) reports lymphedema rates of 8% for breast cancer patients undergoing Sentinel Lymph Node Biopsy and 14% for those undergoing axillary Lymphadenectomy.1 In the 1098122023 AMAROS trial of the European Organization for Research and Treatment of Cancer (EORTC), the rates are 13% to 23% for patients after axillary Lymphadenectomy and 5% to 11% for those treated with Radiotherapy.2 The diagnosis of lymphedema is predominantly clinical, through ORCID IDs: Gustavo Amaral de Abreu: 0009-0003-1538-019X; Diego Alvarez Naranjo: 0009-0005-9997-4634; Gilberto Vaz Teixeira: 0000-0002-0830-7133; Felipe de Borba Chiaramonte Silva: 0009-0006-4647-7068; Edgar Edinson Fernandez Altamiranda: 0009-0007-2910-3184; Sofia Ratchitzki Teixeira: 0009-0006-8261- 2124; Gabriel Manfro: 0009-0000-4518-9175☆ The study was carried out at the CEPON, Florianópolis, SC, Brazil.☆☆ This work received the Alberto Rosseti Ferraz Award at the XXIX Brazilian Congress of SBCCP.☆☆☆ This paper was original submitted and published by the Archives of Head and Neck Surgery. ..

Article Title: Cervical lymphatic tissue as an alternative donor site for the microsurgical treatment of secondary lymphedema in limbs
Article Snippet: .. The B-32 trial of the National Surgical Adjuvant Breast and Bowel Project (NSABP) reports lymphedema rates of 8% for breast cancer patients undergoing Sentinel Lymph Node Biopsy and 14% for those undergoing axillary Lymphadenectomy. ..

Article Title: Luminal A Versus B After Choosing Wisely: Does Lymph Node Surgery Affect Oncologic Outcomes?
Article Snippet: Background.. In 2016, the Choosing Wisely campaign recommended against routine sentinel lymph node biopsy (SLNB) in women ≥ 70 years old diagnosed with early-stage hormone receptor positive (HR+), HER2 negative (HER2−) breast cancer.. No distinction is made between luminal A and luminal B phenotypes, despite luminal B being considered more aggressive.

Article Title: Are Clinically Node-Negative Patients with a Positive Preoperative Axillary Lymph Node Biopsy Appropriate Candidates for Sentinel Lymph Node Biopsy?
Article Snippet: Background.. Whether cN0 patients with image-detected nodal metastases are appropriate for sentinel lymph node biopsy (SLNB) or should proceed directly to axillary lymph node dissection (ALND) or neoadjuvant chemotherapy (NAC) is controversial.. We sought to determine how often ALND is needed with upfront surgery and to identify factors associated with ≥ 3 positive SLNs after a positive preoperative lymph node (LN) biopsy.

Biomarker Discovery:

Article Title: Cervical lymphatic tissue as an alternative donor site for the microsurgical treatment of secondary lymphedema in limbs.
Article Snippet: .. The B-32 trial of the National Surgical Adjuvant Breast and Bowel Project (NSABP) reports lymphedema rates of 8% for breast cancer patients undergoing Sentinel Lymph Node Biopsy and 14% for those undergoing axillary Lymphadenectomy.1 In the 1098122023 AMAROS trial of the European Organization for Research and Treatment of Cancer (EORTC), the rates are 13% to 23% for patients after axillary Lymphadenectomy and 5% to 11% for those treated with Radiotherapy.2 The diagnosis of lymphedema is predominantly clinical, through ORCID IDs: Gustavo Amaral de Abreu: 0009-0003-1538-019X; Diego Alvarez Naranjo: 0009-0005-9997-4634; Gilberto Vaz Teixeira: 0000-0002-0830-7133; Felipe de Borba Chiaramonte Silva: 0009-0006-4647-7068; Edgar Edinson Fernandez Altamiranda: 0009-0007-2910-3184; Sofia Ratchitzki Teixeira: 0009-0006-8261- 2124; Gabriel Manfro: 0009-0000-4518-9175☆ The study was carried out at the CEPON, Florianópolis, SC, Brazil.☆☆ This work received the Alberto Rosseti Ferraz Award at the XXIX Brazilian Congress of SBCCP.☆☆☆ This paper was original submitted and published by the Archives of Head and Neck Surgery. ..

Surround Optical-fiber Immunoassay:

Article Title: Cervical lymphatic tissue as an alternative donor site for the microsurgical treatment of secondary lymphedema in limbs.
Article Snippet: .. The B-32 trial of the National Surgical Adjuvant Breast and Bowel Project (NSABP) reports lymphedema rates of 8% for breast cancer patients undergoing Sentinel Lymph Node Biopsy and 14% for those undergoing axillary Lymphadenectomy.1 In the 1098122023 AMAROS trial of the European Organization for Research and Treatment of Cancer (EORTC), the rates are 13% to 23% for patients after axillary Lymphadenectomy and 5% to 11% for those treated with Radiotherapy.2 The diagnosis of lymphedema is predominantly clinical, through ORCID IDs: Gustavo Amaral de Abreu: 0009-0003-1538-019X; Diego Alvarez Naranjo: 0009-0005-9997-4634; Gilberto Vaz Teixeira: 0000-0002-0830-7133; Felipe de Borba Chiaramonte Silva: 0009-0006-4647-7068; Edgar Edinson Fernandez Altamiranda: 0009-0007-2910-3184; Sofia Ratchitzki Teixeira: 0009-0006-8261- 2124; Gabriel Manfro: 0009-0000-4518-9175☆ The study was carried out at the CEPON, Florianópolis, SC, Brazil.☆☆ This work received the Alberto Rosseti Ferraz Award at the XXIX Brazilian Congress of SBCCP.☆☆☆ This paper was original submitted and published by the Archives of Head and Neck Surgery. ..

Dissection:

Article Title: Risk factors and prognosis of sentinel lymph node metastasis in breast-conserving breast cancer: A retrospective study based on the SEER database
Article Snippet: .. NSABP-B32 study confirmed that negative axillary sentinel lymph node biopsy exempted axillary lymph node dissection. ..

Article Title: Luminal A Versus B After Choosing Wisely: Does Lymph Node Surgery Affect Oncologic Outcomes?
Article Snippet: Background.. In 2016, the Choosing Wisely campaign recommended against routine sentinel lymph node biopsy (SLNB) in women ≥ 70 years old diagnosed with early-stage hormone receptor positive (HR+), HER2 negative (HER2−) breast cancer.. No distinction is made between luminal A and luminal B phenotypes, despite luminal B being considered more aggressive.

Article Title: Are Clinically Node-Negative Patients with a Positive Preoperative Axillary Lymph Node Biopsy Appropriate Candidates for Sentinel Lymph Node Biopsy?
Article Snippet: Background.. Whether cN0 patients with image-detected nodal metastases are appropriate for sentinel lymph node biopsy (SLNB) or should proceed directly to axillary lymph node dissection (ALND) or neoadjuvant chemotherapy (NAC) is controversial.. We sought to determine how often ALND is needed with upfront surgery and to identify factors associated with ≥ 3 positive SLNs after a positive preoperative lymph node (LN) biopsy.

Article Title: Evaluation of Male Breast Cancer and the Application of Sentinel Lymph Node Biopsy: A Multicenter Retrospective Study.
Article Snippet: .. Sentinel lymph node biopsy (SLNB) was introduced in the 1990s as an alternative to axillary lymph node dissection (ALND) for patients with breast cancer who had clinically negative lymph nodes.6 According to the current consensus,7,8 ALND can be avoided in most patients with clinical node-negative regardless of pathologic findings based on NSABP B-32 study,9 etc. ..

Expressing:

Article Title: Luminal A Versus B After Choosing Wisely: Does Lymph Node Surgery Affect Oncologic Outcomes?
Article Snippet: Background.. In 2016, the Choosing Wisely campaign recommended against routine sentinel lymph node biopsy (SLNB) in women ≥ 70 years old diagnosed with early-stage hormone receptor positive (HR+), HER2 negative (HER2−) breast cancer.. No distinction is made between luminal A and luminal B phenotypes, despite luminal B being considered more aggressive.

Control:

Article Title: Are Clinically Node-Negative Patients with a Positive Preoperative Axillary Lymph Node Biopsy Appropriate Candidates for Sentinel Lymph Node Biopsy?
Article Snippet: Background.. Whether cN0 patients with image-detected nodal metastases are appropriate for sentinel lymph node biopsy (SLNB) or should proceed directly to axillary lymph node dissection (ALND) or neoadjuvant chemotherapy (NAC) is controversial.. We sought to determine how often ALND is needed with upfront surgery and to identify factors associated with ≥ 3 positive SLNs after a positive preoperative lymph node (LN) biopsy.

Irradiation:

Article Title: Are Clinically Node-Negative Patients with a Positive Preoperative Axillary Lymph Node Biopsy Appropriate Candidates for Sentinel Lymph Node Biopsy?
Article Snippet: Background.. Whether cN0 patients with image-detected nodal metastases are appropriate for sentinel lymph node biopsy (SLNB) or should proceed directly to axillary lymph node dissection (ALND) or neoadjuvant chemotherapy (NAC) is controversial.. We sought to determine how often ALND is needed with upfront surgery and to identify factors associated with ≥ 3 positive SLNs after a positive preoperative lymph node (LN) biopsy.



Similar Products

86
Sentinella Pharmaceuticals Inc sentinel lymph node biopsy
Sentinel Lymph Node Biopsy, supplied by Sentinella Pharmaceuticals Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sentinel+lymph+node+biopsy/biopsy+lymph+node+sentinel/pm41634779-388-21-36
Average 86 stars, based on 1 article reviews
sentinel lymph node biopsy - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

90
NSABP Foundation sentinel lymph node biopsy
Sentinel Lymph Node Biopsy, supplied by NSABP Foundation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sentinel+lymph+node+biopsy/sentinel+lymph+node+biopsy/pmc12159821-43-23-12
Average 90 stars, based on 1 article reviews
sentinel lymph node biopsy - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Verlag GmbH sentinel lymph node mapping and biopsy
Sentinel Lymph Node Mapping And Biopsy, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sentinel+lymph+node+biopsy/sentinel+lymph+node+biopsy/pm40327185-11-60-34
Average 90 stars, based on 1 article reviews
sentinel lymph node mapping and biopsy - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Aslan Pharmaceuticals avoid axillary sentinel lymph node biopsy after neoadjuvant chemotherapy (aslan) trial
Avoid Axillary Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy (Aslan) Trial, supplied by Aslan Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sentinel+lymph+node+biopsy/avoid+axillary+sentinel+lymph+node+biopsy+after+neoadjuvant+chemotherapy++aslan++trial/pm40233520-71-23-25
Average 90 stars, based on 1 article reviews
avoid axillary sentinel lymph node biopsy after neoadjuvant chemotherapy (aslan) trial - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
NSABP Foundation sentinel lymph node biopsy (slnb)
Sentinel Lymph Node Biopsy (Slnb), supplied by NSABP Foundation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sentinel+lymph+node+biopsy/sentinel+lymphadenectomy++slnb+/pm40188594-21-11-1
Average 90 stars, based on 1 article reviews
sentinel lymph node biopsy (slnb) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
NSABP Foundation sentinel lymph node biopsy (sln
Flowchart of patients according to initial cN status undergoing NAC. Bold boxes refer to excluded patients. List of abbreviations: BC—breast cancer. HCB—Hospital Clinic of Barcelona. NAC—neoadjuvant chemotherapy. c <t>—clinical.</t> <t>SLN—sentinel</t> lymph node biopsy. TAD—targeted axillary dissection. ALND—axillary lymph node dissection. US—ultrasound. MRI—magnetic resonance imaging. FNAC—fine-needle aspiration cytology. CNB—core needle biopsy.
Sentinel Lymph Node Biopsy (Sln, supplied by NSABP Foundation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sentinel+lymph+node+biopsy/sentinel+lymph+node+biopsy/pmc11545455-140-7-23
Average 90 stars, based on 1 article reviews
sentinel lymph node biopsy (sln - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Rambam Health Corporation sentinel lymph node biopsy
Flowchart of patients according to initial cN status undergoing NAC. Bold boxes refer to excluded patients. List of abbreviations: BC—breast cancer. HCB—Hospital Clinic of Barcelona. NAC—neoadjuvant chemotherapy. c <t>—clinical.</t> <t>SLN—sentinel</t> lymph node biopsy. TAD—targeted axillary dissection. ALND—axillary lymph node dissection. US—ultrasound. MRI—magnetic resonance imaging. FNAC—fine-needle aspiration cytology. CNB—core needle biopsy.
Sentinel Lymph Node Biopsy, supplied by Rambam Health Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sentinel+lymph+node+biopsy/sialendoscopy/pm38987034-22-2-12
Average 90 stars, based on 1 article reviews
sentinel lymph node biopsy - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Flowchart of patients according to initial cN status undergoing NAC. Bold boxes refer to excluded patients. List of abbreviations: BC—breast cancer. HCB—Hospital Clinic of Barcelona. NAC—neoadjuvant chemotherapy. c —clinical. SLN—sentinel lymph node biopsy. TAD—targeted axillary dissection. ALND—axillary lymph node dissection. US—ultrasound. MRI—magnetic resonance imaging. FNAC—fine-needle aspiration cytology. CNB—core needle biopsy.

Journal: Cancers

Article Title: Predicting Additional Metastases in Axillary Lymph Node Dissection After Neoadjuvant Chemotherapy: Ratio of Positive/Total Sentinel Nodes

doi: 10.3390/cancers16213638

Figure Lengend Snippet: Flowchart of patients according to initial cN status undergoing NAC. Bold boxes refer to excluded patients. List of abbreviations: BC—breast cancer. HCB—Hospital Clinic of Barcelona. NAC—neoadjuvant chemotherapy. c —clinical. SLN—sentinel lymph node biopsy. TAD—targeted axillary dissection. ALND—axillary lymph node dissection. US—ultrasound. MRI—magnetic resonance imaging. FNAC—fine-needle aspiration cytology. CNB—core needle biopsy.

Article Snippet: For clinically negative axilla (cN0) BC patients, sentinel lymph node biopsy (SLN) after NAC was proven to be feasible and safe according to NSABP-B32 trial results [ ].

Techniques: Dissection, Magnetic Resonance Imaging

Overall population demographics and distribution according to ALND results. Significant p values are reported in bold. a Only 2 cT4b patients fulfilled the inclusion criteria in the cT3/cT4 category; the remainder of the group is composed exclusively of cT3 patients. b For statistical analysis, RECIST criteria categories of progressive disease, stable disease and partial response have been aggregated into a non-complete response group. c Axillary US and breast/axillar MRI were performed at initial diagnosis in all patients included in the study, and breast/axillar MRI after NAC was also scheduled in all patients, except in 4 patients whose data are not available. List of abbreviations: ALND—axillary lymph node dissection;  SLN—sentinel  lymph node; SD—standard deviation; BMI—body mass index; MRI—magnetic resonance imaging; ER—estrogen receptor; PR—progesterone receptor; IHC—immunohistochemical; HR—hormonal receptor; TN—triple negative; NAC—neoadjuvant chemotherapy.

Journal: Cancers

Article Title: Predicting Additional Metastases in Axillary Lymph Node Dissection After Neoadjuvant Chemotherapy: Ratio of Positive/Total Sentinel Nodes

doi: 10.3390/cancers16213638

Figure Lengend Snippet: Overall population demographics and distribution according to ALND results. Significant p values are reported in bold. a Only 2 cT4b patients fulfilled the inclusion criteria in the cT3/cT4 category; the remainder of the group is composed exclusively of cT3 patients. b For statistical analysis, RECIST criteria categories of progressive disease, stable disease and partial response have been aggregated into a non-complete response group. c Axillary US and breast/axillar MRI were performed at initial diagnosis in all patients included in the study, and breast/axillar MRI after NAC was also scheduled in all patients, except in 4 patients whose data are not available. List of abbreviations: ALND—axillary lymph node dissection; SLN—sentinel lymph node; SD—standard deviation; BMI—body mass index; MRI—magnetic resonance imaging; ER—estrogen receptor; PR—progesterone receptor; IHC—immunohistochemical; HR—hormonal receptor; TN—triple negative; NAC—neoadjuvant chemotherapy.

Article Snippet: For clinically negative axilla (cN0) BC patients, sentinel lymph node biopsy (SLN) after NAC was proven to be feasible and safe according to NSABP-B32 trial results [ ].

Techniques: Dissection, Imaging

Axillary surgery details according to ALDN results. Significant p values are reported in bold.

Journal: Cancers

Article Title: Predicting Additional Metastases in Axillary Lymph Node Dissection After Neoadjuvant Chemotherapy: Ratio of Positive/Total Sentinel Nodes

doi: 10.3390/cancers16213638

Figure Lengend Snippet: Axillary surgery details according to ALDN results. Significant p values are reported in bold.

Article Snippet: For clinically negative axilla (cN0) BC patients, sentinel lymph node biopsy (SLN) after NAC was proven to be feasible and safe according to NSABP-B32 trial results [ ].

Techniques:

Patterns of SLN, SLN-R and non-SLN involvement at ALND. ( A ) Number of non-SLN affected at ALND, according to cN status at diagnosis and size of SLN metastasis in the overall population. ( B ) Pattern of non-SLN involvement after ALND, according to SLN-R cut-off ≤ 0.35. ( C ) Number of non-SLN affected at ALND, according to SLN-R cut-off ≤ 0.35 and size of SLN metastasis. ( D ) Number of non-SLN affected at ALND, according to SLN-R cut-off ≤ 0.35 within each IHC subtype. List of abbreviations: nRD—non-residual disease; RD—residual disease; IHC—immunohistochemistry; SLN—sentinel lymph node; ALND—axillary lymph node dissection; ITC—isolated tumor cells; Micro—micrometastases; Macro—macrometastases; HR—hormone receptor; + positive; − negative; TN—triple negative breast cancer. p values refer to Chi-squared tests.

Journal: Cancers

Article Title: Predicting Additional Metastases in Axillary Lymph Node Dissection After Neoadjuvant Chemotherapy: Ratio of Positive/Total Sentinel Nodes

doi: 10.3390/cancers16213638

Figure Lengend Snippet: Patterns of SLN, SLN-R and non-SLN involvement at ALND. ( A ) Number of non-SLN affected at ALND, according to cN status at diagnosis and size of SLN metastasis in the overall population. ( B ) Pattern of non-SLN involvement after ALND, according to SLN-R cut-off ≤ 0.35. ( C ) Number of non-SLN affected at ALND, according to SLN-R cut-off ≤ 0.35 and size of SLN metastasis. ( D ) Number of non-SLN affected at ALND, according to SLN-R cut-off ≤ 0.35 within each IHC subtype. List of abbreviations: nRD—non-residual disease; RD—residual disease; IHC—immunohistochemistry; SLN—sentinel lymph node; ALND—axillary lymph node dissection; ITC—isolated tumor cells; Micro—micrometastases; Macro—macrometastases; HR—hormone receptor; + positive; − negative; TN—triple negative breast cancer. p values refer to Chi-squared tests.

Article Snippet: For clinically negative axilla (cN0) BC patients, sentinel lymph node biopsy (SLN) after NAC was proven to be feasible and safe according to NSABP-B32 trial results [ ].

Techniques: Immunohistochemistry, Dissection, Isolation